None
Quote | Leafbuyer Technologies Inc (OTCMKTS:LBUY)
Last: | $0.025 |
---|---|
Change Percent: | -2.34% |
Open: | $0.0262 |
Close: | $0.0256 |
High: | $0.0262 |
Low: | $0.025 |
Volume: | 6,100 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
News | Leafbuyer Technologies Inc (OTCMKTS:LBUY)
ESSA Pharma Inc. (EPIX) is expected to report $-0.17 for Q1 2024 QuidelOrtho Corp Com (QDEL) is expected to report $2.01 for Q4 2023 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 Portsmouth Square, Inc. (PRSI) is expected to report for Q2 2024 Similarweb Ltd. (SMWB) ...
2023-12-20 08:15:46 ET More on Leafbuyer Technologies Financial information for Leafbuyer Technologies For further details see: Leafbuyer Technologies announces best sales month in company history
Message Board Posts | Leafbuyer Technologies Inc (OTCMKTS:LBUY)
Subject | By | Source | When |
---|---|---|---|
$LBUY: $LBUY to benefit from U.S. Cannabis Legalization | MoneyMaker111 | investorshub | 03/25/2022 3:03:11 PM |
Ok, Thank you. | markflfl | investorshub | 07/27/2021 3:49:02 PM |
$LBUY Holding | outnabout | investorshub | 07/27/2021 3:30:10 PM |
$LBUY = 1 FOR 2??? sell or holding??? | markflfl | investorshub | 07/27/2021 3:02:43 PM |
Company expecting more revenue and less operating expenses. | Deetew | investorshub | 05/29/2021 2:23:16 AM |
News, Short Squeeze, Breakout and More Instantly...
Leafbuyer Technologies Inc Company Name:
LBUY Stock Symbol:
OTCMKTS Market:
ESSA Pharma Inc. (EPIX) is expected to report $-0.17 for Q1 2024 QuidelOrtho Corp Com (QDEL) is expected to report $2.01 for Q4 2023 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 Portsmouth Square, Inc. (PRSI) is expected to report for Q2 2024 Similarweb Ltd. (SMWB) ...
Technology Company Records All Time Record Monthly Sales DENVER, CO / ACCESSWIRE / December 20, 2023 / Leafbuyer Technologies, Inc. ("Leafbuyer" or "the Company") (OTCQB:LBUY), a leading cannabis technology company, announced today the company had cash sales in the month of November of app...
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...